Includes bibliographical references and index.

Drugs of abuse -- Alcohol -- Stimulants -- Hallucinogens -- Opioids -- Inhalants/Aerosols -- Gamma-hydroxybutyrate (GHB)/Sodium Oxybate -- Flunitrazepam (Rohypnol) -- Nicotine/Tobacco -- Treatment of substance use disorders -- Acamaprosate -- Dislfiram -- Naltrexone -- Buprenorphine -- Methadone -- Pharmacotherapy for Nicotine/Tobacco use disorder -- Comparison of treatments for Nicotine/Tobacco use disorder -- Unapproved treatments of psychiatric disorders -- Adrenergic Agents -- Anti-infammatory agents -- Dopaminergic agents -- GABA agents/Anticonvulsants -- Hormones -- NMDA agents -- 5-HT3 Antagonists -- Miscellaneous -- Natural health products -- Gingkgo Biloba -- Kava Kava -- Melatonin -- Omega-3 Polyunsaturated Fatty Acids -- S-Adenosyl-L-Methionine (SAMe) -- St. John's wort -- Valerian -- Vitamins -- Pharmacogenomic information for common psychotropic drugs -- Genotypes affecting pharmacokinetic properties of psychotropic drugs -- Pharmacogenomics-based dose adjustment recommendations and guidelines -- Genotype effects on pharmacokinetic properties of psychotropic drugs -- Glossary -- Drug use in pregnancy and effects on breast milk -- Patient information sheets -- Appendix: Neuroscience-based nomenclature (NbN) -- Index of drugs.